Support Programs to Help Make Ig Therapy Accessible and Affordable

Welcome to Hizentra Connect, a comprehensive resource center for healthcare providers (HCPs) and people who depend on CSL Behring's immune globulin (Ig) therapies.

IgIQ logo

To get the guidance and support you need, call
1-877-355-4447
Monday–Friday, 8 AM to 8 PM ET

How can Hizentra Connect help?

Copay icon

Copay


  • Helps the majority of eligible patients with commercial insurance pay $0 out-of-pocket for Hizentra*
  • Patients can contact CSL Behring's Hizentra Connect Resource Center at 1-877-355-4447 to learn more.
* Subject to terms and conditions of the copay assistance program. To read the full terms and conditions, visit cslbehring.com/patients/support-and-assistance. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.
Assurance icon

Assurance


A gap in insurance shouldn't mean a gap in treatment. CSL Behring understands the stress and hardship caused by a lapse in health insurance. Assurance is designed to help eligible patients, who rely on our Ig therapies, continue to receive treatment even if they experience a lapse in third-party, private health insurance.

Benefits for Patients

Assurance allows patients to build up a reserve of Hizentra at no additional cost. This can be used in the event of a lapse in insurance coverage, so it's important to enroll as soon as possible.*

Advantage for HCPs

Assurance helps to keep patients on track with their treatment protocol during difficult times.

*Enrollment required. Subject to terms and conditions. For the Assurance program, visit cslbehringassurance.com.
Premier Start℠ Sample icon

Patient Assistance Program


  • Provides access to therapies for qualified patients who are uninsured or underinsured

Learn more about the Patient Assistance Program.

book icon

Medicare Coverage


Hizentra is covered under Medicare Part B.*

The convenience of self-infused Hizentra—covered under the same benefit category as IVIg.

Lower patient out-of-pocket cost than with Part D

  • Coverage includes infusion pump, ancillary supplies, medication, and nurse training

No prior authorization required

For updated coverage and comprehensive support, call Hizentra Connect at 1-877-355-4447, Monday–Friday, 8 AM to 8 PM ET.

*100% coverage for those with Medicare Part B and a Medigap plan after Part B annual deductible is met. Coverage of IVIg when administered in a clinical setting. Chart notes must be up to date and include diagnostic criteria.
Voice2Voice icon

Voice2Voice®


  • A unique program that connects PI and CIDP patients and caregivers with people who have direct experience with Hizentra therapy
  • Offers peer-to-peer support, resources, and encouragement*

Voice2Voice
*Voice2Voice advocates are not healthcare professionals or medical experts. For medical questions, patients should contact their healthcare provider. Voice2Voice advocates are compensated by CSL Behring LLC for their time and/or expenses.
Free Trial icon

Free Trial


  • Provides a one-month supply of product, infusion equipment, and training at no cost to your patient
  • Free in-home visits by a trained nurse who will teach patients how to infuse Hizentra
  • Seamless process, from trial and request to follow-up therapy notes provided to your office and the patient's pharmacy
Reimbursement icon

Reimbursement Support


  • Prior authorizations, appeals, and connection to CSL Behring's field reimbursement team
Hizentra Connect logo

To get the guidance and support you need, call
1-877-355-4447
Monday–Friday, 8 AM to 8 PM ET

Get in touch to learn more

Along with the support offered by the knowledgeable staff of Hizentra Connect, your Hizentra representative can also serve as a valuable resource for information about PI and SCIg treatment. Please feel free to utilize their expertise.

Request more information about Hizentra

Of course, a lot of useful information is at your fingertips through this site right now, including Access and Billing Codes and Patient Resources.

View information about Hizentra for:

CIDP

chronic inflammatory demyelinating polyneuropathy

PI

primary immunodeficiency


acuity
You are now leaving the current website.

Do you want to continue?

No Yes